Berberine maintains the neutrophil N1 phenotype to reverse cancer cell resistance to doxorubicin
- Type
- Retraction
- Notice date
- 12/7/2023 0:00
- Journal
- Frontiers in Pharmacology
- Publisher
- Frontiers
- Notice DOI
- 10.3389/fphar.2023.1349235
- Original paper DOI
- 10.3389/fphar.2019.01658
Reasons
- Concerns/Issues about Image
- Investigation by Journal/Publisher
- Unreliable Data
- Unreliable Results and/or Conclusions